© 2020 by NINA CAPITAL

 data-artwork by giorgia lupi

WHAT WE BELIEVE

In our investment approach, we are inspired by a vision for the future in which data derived through computing, IoT, and sensor technologies deliver meaningful insight for improving health and the provision of care. We are interested in all specialties, and especially committed to addressing needs in the areas of oncology, aging, and cardiovascular. 

 

We are informed by a Stanford-born methodology of health technology innovation known as Biodesign, proven to de-risk the process of new health technology venture creation. 

 

We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with advanced data science and IT-enabled products and services. We look for and support founders determined to effectively and efficiently serve these participants on this continent and internationally.

 

Our goal is to help them ready for Series A, as well as supporting the early growth of Series A companies into international markets., co-investing alongside other european and international firms.


We invest in European companies as well as in selected US companies with significant ties to Europe.

We are committed

to founders with international ambitions.

more

We understand the complexity of healthcare.

more

We believe Europe's growing technology ecosystem has global impact potential.

more

We have a bias for teams that are interdisciplinary & diverse along multiple dimensions.

more

We have a special interest in digital and information technology solutions that respond to unmet needs.

more

We believe in the power of mentorship.

more

HEALTH TECHNOLOGY

with focus on
digital and information technology

EARLY STAGE

investing in 

seed and series A companies

EUROPEAN

office in Barcelona

motivated by the opportunity to tell stories of success built in Europe

VALUE DRIVEN

we uphold principles of need-driven innovation and diversity

confident they generate the highest value in health technology businesses